What is Entourage Health Corp. (ETRGF)?

Entourage Health Corp. (ETRGF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of ETRGF?

The current price of ETRGF is $0.00. Prices are updated in real time on Stocks360.

What is ETRGF's price-to-earnings (PE) ratio?

ETRGF's trailing twelve-month PE ratio is -0.04, based on current price and earnings per share data available on Stocks360.

What is ETRGF's market capitalization?

ETRGF's market capitalization is $1,233,548.00, placing it in the small-cap tier.

Entourage Health Corp. (ETRGF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$1.23M

PE (TTM)

-0.04

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.81

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.01

Avg Volume

N/A

Volume

500.00K

Entourage Health Corp. (ETRGF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.23M. Trailing PE -0.04. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Entourage Health Corp.

Entourage Health Corp., headquartered in Toronto, Canada, is a Canadian enterprise specializing in the cultivation and distribution of various cannabis products. The company serves both the medical and recreational consumer markets across Canada. Its comprehensive portfolio includes live cannabis plants, dried flower, oils, topical applications, concentrated extracts, and edible formulations. These diverse offerings are marketed under prominent brands such as Color Cannabis, Saturday Cannabis, Starseed Medicinals, and Mary's Medicinals. The organization adopted its current name, Entourage Health Corp., in July 2021, having previously operated as WeedMD Inc.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.04×
P/S (TTM)	0.04×
P/B	-0.01×
P/FCF (TTM)	-0.15×
EV / EBITDA	-7.11×
EV / Sales	3.74×
Earnings Yield	-2679.81%
Free Cash Flow Yield	-662.81%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$152.15M
Revenue (TTM)	$40.71M
Net Income (TTM)	-$46.25M
Free Cash Flow (TTM)	$12.95M
Net Debt	$150.43M
Working Capital	-$146.91M
Gross Margin	9.11%
Operating Margin	-52.51%
Net Margin	-113.40%
Return on Equity	37.15%
Return on Invested Capital	-149.63%